IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation

BACKGROUND: At our institution, until April 2013, patients who showed early donor specific anti-HLA antibodies (DSA) after lung transplantation were preemptively treated with therapeutic plasma exchange (tPE) and a single dose of Rituximab. In April 2013, we moved to a therapy based on IgM-enriched...

Descripción completa

Detalles Bibliográficos
Autores principales: Ius, Fabio, Sommer, Wiebke, Kieneke, Daniela, Tudorache, Igor, Kühn, Christian, Avsar, Murat, Siemeni, Thierry, Salman, Jawad, Erdfelder, Carolin, Verboom, Murielle, Kielstein, Jan, Tecklenburg, Andreas, Greer, Mark, Hallensleben, Michael, Blasczyk, Rainer, Schwerk, Nicolaus, Gottlieb, Jens, Welte, Tobias, Haverich, Axel, Warnecke, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120772/
https://www.ncbi.nlm.nih.gov/pubmed/26714123
http://dx.doi.org/10.1097/TP.0000000000001027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120772/
https://www.ncbi.nlm.nih.gov/pubmed/26714123
http://dx.doi.org/10.1097/TP.0000000000001027

Ejemplares similares